Page last updated: 2024-10-24

phosphoric diester hydrolase activity

Definition

Target type: molecularfunction

Catalysis of the hydrolysis of a phosphodiester to give a phosphomonoester and a free hydroxyl group. [EC:3.1.4.-]

Phosphoric diester hydrolase activity refers to the enzymatic hydrolysis of a phosphoric diester bond. This is a fundamental process in many cellular pathways, playing a crucial role in:

- **Nucleic acid metabolism:** Phosphoric diester hydrolases are involved in the breakdown of DNA and RNA, facilitating replication, transcription, and repair. They cleave the phosphodiester bonds linking nucleotides, releasing individual nucleotides or oligonucleotides.
- **Signal transduction:** Many signaling molecules, such as cyclic AMP (cAMP), are generated by phosphoric diester hydrolases. These molecules act as second messengers, transmitting signals within cells and activating downstream pathways.
- **Lipid metabolism:** Phospholipases, a class of phosphoric diester hydrolases, hydrolyze phospholipids in cell membranes, releasing signaling molecules and modifying membrane structure.
- **Carbohydrate metabolism:** Certain phosphoric diester hydrolases play a role in the breakdown of sugar phosphates, releasing inorganic phosphate and facilitating energy production.

The catalytic mechanism typically involves the formation of a transient covalent intermediate between the enzyme and the substrate, followed by hydrolysis of the intermediate. The reaction requires a nucleophile, usually a water molecule, to attack the phosphorus atom of the phosphodiester bond.

The activity of phosphoric diester hydrolases is highly specific, with different enzymes targeting specific substrates. This specificity arises from the structure of the active site, which recognizes and binds to the substrate molecule, facilitating the hydrolysis reaction.

Mutations or dysregulation of phosphoric diester hydrolases can lead to various diseases, affecting processes like DNA replication, cell signaling, and lipid metabolism.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Sphingomyelin phosphodiesterase 3A sphingomyelin phosphodiesterase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NY59]Homo sapiens (human)
DNA-(apurinic or apyrimidinic site) endonucleaseA DNA-(apurinic or apyrimidinic site) endonuclease that is encoded in the genome of human. [PRO:DNx, UniProtKB:P27695]Homo sapiens (human)
Sphingomyelin phosphodiesterase 2A sphingomyelin phosphodiesterase 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60906]Homo sapiens (human)

Compounds (19)

CompoundDefinitionClassesRoles
aurintricarboxylic acidaurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'.

Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.
monohydroxybenzoic acid;
quinomethanes;
tricarboxylic acid
fluorochrome;
histological dye;
insulin-like growth factor receptor 1 antagonist
hycanthonehycanthone : A thioxanthen-9-one compound having a hydroxymethyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. It was formerly used (particularly as the monomethanesulfonic acid salt) as a schistosomicide for individual or mass treatement of infection with Schistosoma haematobium and S. mansoni, but due to its toxicity and concern about possible carcinogenicity, it has been replaced by other drugs such as praziquantel.

Hycanthone: Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE.
thioxanthenesmutagen;
schistosomicide drug
lucanthonelucanthone : A thioxanthen-9-one compound having a methyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. Formerly used for the treatment of schistosomiasis. It is a prodrug, being metabolised to hycanthone.

Lucanthone: One of the SCHISTOSOMICIDES, it has been replaced largely by HYCANTHONE and more recently PRAZIQUANTEL. (From Martindale The Extrapharmacopoeia, 30th ed., p46)
thioxanthenesadjuvant;
antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
mutagen;
photosensitizing agent;
prodrug;
schistosomicide drug
mitoxantrone hydrochloridehydrochlorideantineoplastic agent
7-nitro-1h-indole-2-carboxylic acid7-nitro-1H-indole-2-carboxylic acid: acts on AP endonuclease, 3'-phosphodiesterase, and 3'-phosphatase activities of APE1; structure in first source
3,3',4,4',5,5'-hexabromobiphenyl
6-hydroxydopa6-hydroxydopa: RN given refers to cpd without isomeric designationnon-proteinogenic alpha-amino acid
tanshinone ii atashinone IIA: a cardiovascular agent with antineoplastic activity; isolated from Salvia miltiorrhiza; structure in first sourceabietane diterpenoid
1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dionepyrimidotriazine
2-[[5-(dimethylsulfamoyl)-1H-indol-3-yl]methylidene]propanedioic acid diethyl esterindoles
1,6-dimethyl-3-propylpyrimido[5,4-e][1,2,4]triazine-5,7-dionepyrimidotriazine
cambinolcambinol: inhibitor of human silent information regulator 2 enzymes; structure in first source
myricetin7-hydroxyflavonol;
hexahydroxyflavone
antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
ag 538AG 538: an IGF-1 receptor kinase inhibitor; structure in first source
e 3330E 3330: structure given in first source; MW 378.47
scyphostatinscyphostatin: a neutral sphingomyelinase inhibitor isolated from Trichopeziza mollissima; structure in first sourcecyclohexenones
N-[3-(1,3-benzothiazol-2-yl)-5,6-dihydro-4H-thieno[2,3-c]pyrrol-2-yl]acetamidebenzothiazoles
thiolactomycinthiolactomycin: from actinomycetes; structure given in first source
galloflavingalloflavin: structure in first source